CTRI/2024/02/063292
Not Yet Recruiting
Phase 3
Assessment of Effectiveness of Empagliflozin in the Management of Anemia in Type 2 Diabetes Patients with Early Stage of Chronic Kidney Disease- A Prospective Randomised COntrol Study - NI
SRM Insitute of Science and Technology0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- SRM Insitute of Science and Technology
- Status
- Not Yet Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Estimated glomerular filtration rate 45 to 90 ml per minute .
- •Diabetic patients HbA1C greater than 6\.5 percent
- •Patients with haemoglobin less than 13\.0 g per dL in males.
- •Haemoglobin less than 12\.0 g per dL in females.
Exclusion Criteria
- •End Stage Renal Disease patients Stage 4
- •Patients with hereditary iron metabolism disorders.
- •Patients with Type 1 Diabetes mellitus.
- •Patients with pre\-existing Urinary tract or Genital infections and patients who develop this complication during the study.
- •Patient with pyelonephritis.
- •Patients already taking diuretics.
- •Pregnant and Lactating women.
- •Treatment with any other investigational drug within the previous 30 days of inclusion in the study.
- •Any therapy or condition that would pose a risk to the patient or make it difficult to comply with study requirements.
- •Difficulty in Socio Culture Communication.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Evaluation of the effectiveness of Empagliflozin on metabolic factors and liver function testsIRCT20191209045671N3Semnan University of Medical Sciences60
Not Yet Recruiting
Phase 3
Evaluation of the effect of Empagliflozin on the severity of heart failure symptoms and echocardiography parameters in patients with congenital heart diseases with left-to-right shuntIRCT20120520009801N11Mashhad University of Medical Sciences44
Completed
Phase 3
Effect of Empagliflozin in prevention of kidney stone parametersIRCT20211203053261N2Hamedan University of Medical Sciences138
Recruiting
Phase 4
The effect of empagliflozin in patients with idiopathic edemaIdiopathic edema.Edema, unspecifiedR60.9IRCT20230314057712N1Ahvaz University of Medical Sciences70
Recruiting
Phase 3
Effect of Empagliflozin in PrediabetesCondition 1: Impaired fasting glucose. Condition 2: Impaired glucose tolerance.Impaired fasting glucoseImpaired glucose tolerance (oral)R73.01R73.02IRCT20220902055858N1Shahre-kord University of Medical Sciences90